<DOC>
	<DOCNO>NCT00699699</DOCNO>
	<brief_summary>This observational non-interventional study design demonstrate improvement physical function COPD patient treatment Spiriva Respimat allow adverse event record evaluate .</brief_summary>
	<brief_title>Observational Non-Interventional Study With Spiriva Respimat COPD Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>COPD patient require treatment longacting anticholinergic Patients recruit general specific contraindication list Patient information leaflet Summary Product Characteristics applies . Spiriva® Respimat® contraindicate patient hypersensitivity tiotropium bromide , atropine derivative , e.g . ipratropium oxitropium excipients .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease ( COPD )</keyword>
</DOC>